Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 2, 2022	4	Statement of changes in beneficial ownership of securities	0001562180-22-002165.pdf 0001562180-22-002165.rtf 0001562180-22-002165.xls View HTML
March 2, 2022	4	Statement of changes in beneficial ownership of securities	0001562180-22-002160.pdf 0001562180-22-002160.rtf 0001562180-22-002160.xls View HTML
March 2, 2022	4	Statement of changes in beneficial ownership of securities	0001562180-22-002162.pdf 0001562180-22-002162.rtf 0001562180-22-002162.xls View HTML
March 2, 2022	4	Statement of changes in beneficial ownership of securities	0001562180-22-002166.pdf 0001562180-22-002166.rtf 0001562180-22-002166.xls View HTML
March 1, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-061300.pdf 0001193125-22-061300.rtf 0001193125-22-061300.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2022	POSASR	POSASR	0001193125-22-061326.pdf 0001193125-22-061326.rtf 0001193125-22-061326.xls View HTML
March 1, 2022	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001628280-22-004522.pdf 0001628280-22-004522.rtf 0001628280-22-004522.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2022	POS AM	Post-effective amendment to an S-Type filing	0001193125-22-061620.pdf 0001193125-22-061620.rtf 0001193125-22-061620.xls View HTML
February 22, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-047773.pdf 0001193125-22-047773.rtf 0001193125-22-047773.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 18, 2022	4/A	Amendment to a previously filed 4	0001562180-22-001654.pdf 0001562180-22-001654.rtf 0001562180-22-001654.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax